Detection of SARS-CoV-2 variants by Abbott molecular, antigen, and serological tests

Mary A Rodgers, Rahul Batra, Luke B Snell, David Daghfal, Richard Roth, Shihai Huang, Stephen Kovacs, Gaia Nebbia, Sam Douthwaite, Gavin A Cloherty
doi: https://doi.org/10.1101/2021.04.24.21256045

Article Information

doi 
https://doi.org/10.1101/2021.04.24.21256045
History 
  • April 26, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.

Author Information

  1. Mary A Rodgers*,1,
  2. Rahul Batra2,
  3. Luke B Snell2,
  4. David Daghfal1,
  5. Richard Roth3,
  6. Shihai Huang4,
  7. Stephen Kovacs5,
  8. Gaia Nebbia2,
  9. Sam Douthwaite2 and
  10. Gavin A Cloherty1
  1. 1Abbott Diagnostics, Abbott Park, IL 60064
  2. 2Guy’s and St Thomas’ NHS Foundation, London, UK
  3. 3Abbott Rapid Diagnostics, San Diego, CA
  4. 4Abbott Molecular Diagnostics, Des Plaines, IL
  5. 5Abbott Rapid Diagnostics, Scarborough, ME
  1. ↵*Corresponding author: Mary A Rodgers, 100 Abbott Park Rd, Abbott Park, IL 60064, mary.rodgers{at}abbott.com
Back to top
Posted April 26, 2021.
Download PDF
Data/Code
Email
Detection of SARS-CoV-2 variants by Abbott molecular, antigen, and serological tests
Mary A Rodgers, Rahul Batra, Luke B Snell, David Daghfal, Richard Roth, Shihai Huang, Stephen Kovacs, Gaia Nebbia, Sam Douthwaite, Gavin A Cloherty
medRxiv 2021.04.24.21256045; doi: https://doi.org/10.1101/2021.04.24.21256045
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area